ベインのウェブサイトは、ユーザーの、利便性の向上、と機能改善のために、クッキーを使用しています。詳細は、弊社のプライバシーポリシーをご参照ください。このサイト閲覧を継続されることで、クッキーの使用についてご了承いただいたことになります。

スナップチャート

Post–Covid-19, Doctors Want Both In-Person and Virtual Visits with Sales Reps

The pandemic has more physicians asking for remote support, but the majority will still want some in-person visits.

スナップチャート

Post–Covid-19, Doctors Want Both In-Person and Virtual Visits with Sales Reps
en

So much has gone virtual due to Covid-19, but physicians still value in-person sales and service visits, according to Bain & Company’s latest survey of frontline providers, conducted with Dynata. Prior to Covid, about three-fourths of physicians preferred face-to-face engagement with medtech and pharmaceutical reps. Today, more are open to virtual approaches and a reduction in visit frequency, but a majority still prefer at least some in-person interaction once the pandemic passes. To address these shifting customer preferences, medtech and pharma companies will need to continue in-person interactions while adding digital capabilities.

Related Insights

Coronavirus

As the global pandemic deepens and the human cost of Covid-19 rises, the novel coronavirus outbreak is sending shocks through the world economy. But across industries, companies can take action now to protect their employees and customers and minimize the economic damage.

About the Research

Data powered by Dynata, a leading global first-party data and insights platform.

Tags

お気軽にご連絡下さい

私達は、グローバルに活躍する経営者が抱える最重要経営課題に対して、厳しい競争環境の中でも成長し続け、「結果」を出すために支援しています。